Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US
William Yang Wang(University of California, Santa Barbara), Rong Xu(Case Western Reserve University), Xin Qi(University School), David C. Kaelber(MetroHealth), George Perry(Case Western Reserve University), QuangQiu Wang(Case Western Reserve University), Nora D. Volkow(National Institute on Drug Abuse), Mark E. Gurney(California Institute of Technology), Pamela B. Davis(Case Western Reserve University)
Cited by 140
Related Papers
Neurocircuitry of Addiction
|Neuropsychopharmacology|2009|5.2k
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5k
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
|Nature Genetics|2007|1.1k
Addiction: Beyond dopamine reward circuitry
|Proceedings of the National Academy of Sciences|2011|935
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
|JAMA Psychiatry|2016|856